Description
The DoW Neurofibromatosis Synergistic Idea Award supports new ideas that represent synergistic approaches to neurofibromatosis research involving two or three Principal Investigators. The award requires a pre-application and a full application, and the proposed research project must be supported by preliminary and/or published data relevant to neurofibromatosis. The award has a maximum period of performance of 3 years and a cost cap of $3.2M. The funding opportunity encourages applications from investigators working in a wide spectrum of disciplines, including basic science, engineering, bioinformatics, population science, translational research, and clinical research. Some key areas of emphasis for this award include NF2- and schwannomatosis-related areas, endpoint validation, biomarker discovery, and technological innovation.
• The award requires more than one PI, with one PI identified as the Initiating PI and responsible for the majority of administrative tasks.
• The award encourages multidisciplinary and multi-institutional collaborations.
• The award requires a plan for interactions among all PIs and organizations involved, including communication, coordination of research progress and results, and data sharing.
• The award has a maximum period of performance of 3 years and a cost cap of $3.2M.
• The funding opportunity encourages applications from investigators working in a wide spectrum of disciplines.